- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-24-mer
- Ligands
- 12 x CWA: (4R)-4-[5-(difluoromethyl)-1H-imidazol-1-yl]-3,3-dimethyl-3,4-dihydro-1H-2-benzopyran-1-one(Non-covalent)
- 84 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 2 residues within 4Å:- Chain A: S.121, K.122
Ligand excluded by PLIPSO4.3: 7 residues within 4Å:- Chain A: S.39, P.40, S.41
- Chain I: E.134, R.137, H.138
- Ligands: CWA.1
Ligand excluded by PLIPSO4.4: 4 residues within 4Å:- Chain A: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.5: 5 residues within 4Å:- Chain A: G.9, T.10, K.42, R.88
- Ligands: CWA.1
Ligand excluded by PLIPSO4.8: 2 residues within 4Å:- Chain B: S.121, K.122
Ligand excluded by PLIPSO4.9: 7 residues within 4Å:- Chain B: S.39, P.40, S.41
- Chain L: E.134, R.137, H.138
- Ligands: CWA.7
Ligand excluded by PLIPSO4.10: 4 residues within 4Å:- Chain B: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.11: 5 residues within 4Å:- Chain B: G.9, T.10, K.42, R.88
- Ligands: CWA.7
Ligand excluded by PLIPSO4.14: 2 residues within 4Å:- Chain C: S.121, K.122
Ligand excluded by PLIPSO4.15: 7 residues within 4Å:- Chain C: S.39, P.40, S.41
- Chain J: E.134, R.137, H.138
- Ligands: CWA.13
Ligand excluded by PLIPSO4.16: 4 residues within 4Å:- Chain C: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.17: 5 residues within 4Å:- Chain C: G.9, T.10, K.42, R.88
- Ligands: CWA.13
Ligand excluded by PLIPSO4.20: 2 residues within 4Å:- Chain D: S.121, K.122
Ligand excluded by PLIPSO4.21: 7 residues within 4Å:- Chain D: S.39, P.40, S.41
- Chain K: E.134, R.137, H.138
- Ligands: CWA.19
Ligand excluded by PLIPSO4.22: 4 residues within 4Å:- Chain D: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.23: 5 residues within 4Å:- Chain D: G.9, T.10, K.42, R.88
- Ligands: CWA.19
Ligand excluded by PLIPSO4.26: 2 residues within 4Å:- Chain E: S.121, K.122
Ligand excluded by PLIPSO4.27: 7 residues within 4Å:- Chain A: E.134, R.137, H.138
- Chain E: S.39, P.40, S.41
- Ligands: CWA.25
Ligand excluded by PLIPSO4.28: 4 residues within 4Å:- Chain E: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.29: 5 residues within 4Å:- Chain E: G.9, T.10, K.42, R.88
- Ligands: CWA.25
Ligand excluded by PLIPSO4.32: 2 residues within 4Å:- Chain F: S.121, K.122
Ligand excluded by PLIPSO4.33: 7 residues within 4Å:- Chain D: E.134, R.137, H.138
- Chain F: S.39, P.40, S.41
- Ligands: CWA.31
Ligand excluded by PLIPSO4.34: 4 residues within 4Å:- Chain F: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.35: 5 residues within 4Å:- Chain F: G.9, T.10, K.42, R.88
- Ligands: CWA.31
Ligand excluded by PLIPSO4.38: 2 residues within 4Å:- Chain G: S.121, K.122
Ligand excluded by PLIPSO4.39: 7 residues within 4Å:- Chain B: E.134, R.137, H.138
- Chain G: S.39, P.40, S.41
- Ligands: CWA.37
Ligand excluded by PLIPSO4.40: 4 residues within 4Å:- Chain G: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.41: 5 residues within 4Å:- Chain G: G.9, T.10, K.42, R.88
- Ligands: CWA.37
Ligand excluded by PLIPSO4.44: 2 residues within 4Å:- Chain H: S.121, K.122
Ligand excluded by PLIPSO4.45: 7 residues within 4Å:- Chain C: E.134, R.137, H.138
- Chain H: S.39, P.40, S.41
- Ligands: CWA.43
Ligand excluded by PLIPSO4.46: 4 residues within 4Å:- Chain H: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.47: 5 residues within 4Å:- Chain H: G.9, T.10, K.42, R.88
- Ligands: CWA.43
Ligand excluded by PLIPSO4.50: 2 residues within 4Å:- Chain I: S.121, K.122
Ligand excluded by PLIPSO4.51: 7 residues within 4Å:- Chain E: E.134, R.137, H.138
- Chain I: S.39, P.40, S.41
- Ligands: CWA.49
Ligand excluded by PLIPSO4.52: 4 residues within 4Å:- Chain I: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.53: 5 residues within 4Å:- Chain I: G.9, T.10, K.42, R.88
- Ligands: CWA.49
Ligand excluded by PLIPSO4.56: 2 residues within 4Å:- Chain J: S.121, K.122
Ligand excluded by PLIPSO4.57: 7 residues within 4Å:- Chain H: E.134, R.137, H.138
- Chain J: S.39, P.40, S.41
- Ligands: CWA.55
Ligand excluded by PLIPSO4.58: 4 residues within 4Å:- Chain J: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.59: 5 residues within 4Å:- Chain J: G.9, T.10, K.42, R.88
- Ligands: CWA.55
Ligand excluded by PLIPSO4.62: 2 residues within 4Å:- Chain K: S.121, K.122
Ligand excluded by PLIPSO4.63: 7 residues within 4Å:- Chain F: E.134, R.137, H.138
- Chain K: S.39, P.40, S.41
- Ligands: CWA.61
Ligand excluded by PLIPSO4.64: 4 residues within 4Å:- Chain K: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.65: 5 residues within 4Å:- Chain K: G.9, T.10, K.42, R.88
- Ligands: CWA.61
Ligand excluded by PLIPSO4.68: 2 residues within 4Å:- Chain L: S.121, K.122
Ligand excluded by PLIPSO4.69: 7 residues within 4Å:- Chain G: E.134, R.137, H.138
- Chain L: S.39, P.40, S.41
- Ligands: CWA.67
Ligand excluded by PLIPSO4.70: 4 residues within 4Å:- Chain L: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.71: 5 residues within 4Å:- Chain L: G.9, T.10, K.42, R.88
- Ligands: CWA.67
Ligand excluded by PLIPSO4.73: 2 residues within 4Å:- Chain M: S.121, K.122
Ligand excluded by PLIPSO4.74: 4 residues within 4Å:- Chain M: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.75: 5 residues within 4Å:- Chain M: L.73, L.102
- Chain Q: L.131, E.134, V.135
Ligand excluded by PLIPSO4.77: 2 residues within 4Å:- Chain N: S.121, K.122
Ligand excluded by PLIPSO4.78: 4 residues within 4Å:- Chain N: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.79: 5 residues within 4Å:- Chain N: L.73, L.102
- Chain S: L.131, E.134, V.135
Ligand excluded by PLIPSO4.81: 2 residues within 4Å:- Chain O: S.121, K.122
Ligand excluded by PLIPSO4.82: 4 residues within 4Å:- Chain O: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.83: 5 residues within 4Å:- Chain O: L.73, L.102
- Chain T: L.131, E.134, V.135
Ligand excluded by PLIPSO4.85: 2 residues within 4Å:- Chain P: S.121, K.122
Ligand excluded by PLIPSO4.86: 4 residues within 4Å:- Chain P: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.87: 5 residues within 4Å:- Chain P: L.73, L.102
- Chain R: L.131, E.134, V.135
Ligand excluded by PLIPSO4.89: 2 residues within 4Å:- Chain Q: S.121, K.122
Ligand excluded by PLIPSO4.90: 4 residues within 4Å:- Chain Q: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.91: 5 residues within 4Å:- Chain Q: L.73, L.102
- Chain U: L.131, E.134, V.135
Ligand excluded by PLIPSO4.93: 2 residues within 4Å:- Chain R: S.121, K.122
Ligand excluded by PLIPSO4.94: 4 residues within 4Å:- Chain R: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.95: 5 residues within 4Å:- Chain R: L.73, L.102
- Chain W: L.131, E.134, V.135
Ligand excluded by PLIPSO4.97: 2 residues within 4Å:- Chain S: S.121, K.122
Ligand excluded by PLIPSO4.98: 4 residues within 4Å:- Chain S: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.99: 5 residues within 4Å:- Chain S: L.73, L.102
- Chain X: L.131, E.134, V.135
Ligand excluded by PLIPSO4.101: 2 residues within 4Å:- Chain T: S.121, K.122
Ligand excluded by PLIPSO4.102: 4 residues within 4Å:- Chain T: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.103: 5 residues within 4Å:- Chain T: L.73, L.102
- Chain V: L.131, E.134, V.135
Ligand excluded by PLIPSO4.105: 2 residues within 4Å:- Chain U: S.121, K.122
Ligand excluded by PLIPSO4.106: 4 residues within 4Å:- Chain U: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.107: 5 residues within 4Å:- Chain M: L.131, E.134, V.135
- Chain U: L.73, L.102
Ligand excluded by PLIPSO4.109: 2 residues within 4Å:- Chain V: S.121, K.122
Ligand excluded by PLIPSO4.110: 4 residues within 4Å:- Chain V: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.111: 5 residues within 4Å:- Chain O: L.131, E.134, V.135
- Chain V: L.73, L.102
Ligand excluded by PLIPSO4.113: 2 residues within 4Å:- Chain W: S.121, K.122
Ligand excluded by PLIPSO4.114: 4 residues within 4Å:- Chain W: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.115: 5 residues within 4Å:- Chain P: L.131, E.134, V.135
- Chain W: L.73, L.102
Ligand excluded by PLIPSO4.117: 2 residues within 4Å:- Chain X: S.121, K.122
Ligand excluded by PLIPSO4.118: 4 residues within 4Å:- Chain X: H.18, R.91, S.128, S.129
Ligand excluded by PLIPSO4.119: 5 residues within 4Å:- Chain N: L.131, E.134, V.135
- Chain X: L.73, L.102
Ligand excluded by PLIP- 24 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.6: 5 residues within 4Å:- Chain A: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.12: 5 residues within 4Å:- Chain B: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.18: 5 residues within 4Å:- Chain C: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.24: 5 residues within 4Å:- Chain D: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.30: 5 residues within 4Å:- Chain E: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.36: 5 residues within 4Å:- Chain F: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.42: 5 residues within 4Å:- Chain G: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.48: 5 residues within 4Å:- Chain H: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.54: 5 residues within 4Å:- Chain I: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.60: 5 residues within 4Å:- Chain J: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.66: 5 residues within 4Å:- Chain K: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.72: 5 residues within 4Å:- Chain L: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.76: 5 residues within 4Å:- Chain M: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.80: 5 residues within 4Å:- Chain N: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.84: 5 residues within 4Å:- Chain O: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.88: 5 residues within 4Å:- Chain P: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.92: 5 residues within 4Å:- Chain Q: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.96: 5 residues within 4Å:- Chain R: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.100: 5 residues within 4Å:- Chain S: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.104: 5 residues within 4Å:- Chain T: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.108: 5 residues within 4Å:- Chain U: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.112: 5 residues within 4Å:- Chain V: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.116: 5 residues within 4Å:- Chain W: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIPDMS.120: 5 residues within 4Å:- Chain X: T.26, Q.27, M.28, F.29, D.30
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Proudfoot, A. et al., High-Confidence Protein-Ligand Complex Modeling by NMR-Guided Docking Enables Early Hit Optimization. J. Am. Chem. Soc. (2017)
- Release Date
- 2017-12-27
- Peptides
- Phosphopantetheine adenylyltransferase: ABCDEFGHIJKLMNOPQRSTUVWX
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
BC
BD
BE
BF
BG
BH
BI
BJ
BK
BL
BM
AN
AO
AP
AQ
AR
AS
AT
AU
AV
AW
AX
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-24-mer
- Ligands
- 12 x CWA: (4R)-4-[5-(difluoromethyl)-1H-imidazol-1-yl]-3,3-dimethyl-3,4-dihydro-1H-2-benzopyran-1-one(Non-covalent)
- 84 x SO4: SULFATE ION(Non-functional Binders)
- 24 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Proudfoot, A. et al., High-Confidence Protein-Ligand Complex Modeling by NMR-Guided Docking Enables Early Hit Optimization. J. Am. Chem. Soc. (2017)
- Release Date
- 2017-12-27
- Peptides
- Phosphopantetheine adenylyltransferase: ABCDEFGHIJKLMNOPQRSTUVWX
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
BC
BD
BE
BF
BG
BH
BI
BJ
BK
BL
BM
AN
AO
AP
AQ
AR
AS
AT
AU
AV
AW
AX
A